EGFR and non-small cell lung carcinoma: The negative correlations of SGLT1 expression with overall and progression-free survival rates were also observed in both NSCLC subpopulations; in patients with wt EGFR tumors (Fig. 5c, d) and those with EGFR mutations (Fig. 5e, f), respectively.